UBRELVY
Identification of Ubrelvy
| No description |
Google image searchProduct monograph
Active ingredient
ubrogepant, 50 MG
DIN: 02532530
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 11-MAY-2023
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
- N02CD — Calcitonin gene-related peptide (CGRP) antagonists (ATC, ATC/DDD)
- N02CD04 — UBROGEPANT (ATC/DDD)
